S16 - MS Characterizations and Tools for Measurement

Event Time: Monday April 24, 2017 3:30 pm to 5:30 pm
Topic(s): MS and CNS Inflammatory Disease
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Genetic descriptors of a multiple sclerosis cohort Noriko Isobe, MD
Dr. Isobe has nothing to disclose.

3:42 PM 002 A Global Epidemiological Forecast of Multiple Sclerosis and Disease Subtypes Sunali Goonesekera
Dr. Goonesekera has received personal compensation for activities with Decision Resources Group as an employee.

3:54 PM 003 Progressive degeneration of RNFL and GCL is seen in pediatric MS in comparison to monophasic demyelination and controls Giulia Longoni, MD
Dr. Longoni has nothing to disclose.

4:06 PM 004 Sample sizes and clinical relevance of MS-specific atrophy markers: A comprehensive, unbiased, simulation-based method accounting for normal aging Christina Azevedo, MD
Dr. Azevedo has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi-Genzyme, Genentech, Novartis, and Hoffman-LaRoche.

4:18 PM 005 Ofatumumab versus teriflunomide in relapsing MS: adaptive design of two Phase 3 studies (ASCLEPIOS I and ASCLEPIOS II) Stephen L Hauser, MD
Dr. Hauser has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Symbiotix, Annexon, Bionure, and Molecular Stethoscope. Dr. Hauser has received compensation for serving on the Board of Directors of Neurona.

4:30 PM 006 Microstructural Deterioration in Multiple Sclerosis Patients Meeting Criteria for “no evidence of disease activity”: Correlations with Clinical Variables Dylan Sperling
Dr. Sperling has nothing to disclose.

4:42 PM 007 Upper Cervical Cord Area Atrophy for Clinical Trials in Multiple Sclerosis Esha Datta
Dr. Datta has nothing to disclose.

4:54 PM 008 Circulating microRNAs are associated with acute inflammation in patients with multiple sclerosis. Maria Antonietta Mazzola, MD
Dr. Mazzola has nothing to disclose.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses